A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| C16 LPA (ammonium salt) | Lysophosphatidic acid (LPA) belongs to a class of phospholipids that has a glycerol backbone attached by a phosphate group, an aliphatic chain and a hydroxyl group. It has a free hydroxyl and phosphate moiety. It is the major constituent of serum. Alternative Names: 1-O-hexadecyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt); 1-hexadecyl-sn-glycero-3-phosphate (ammonium salt); PA(16:0e/0:0) (ammonium salt). Grades: >99%. CAS No. 799279-66-6. Molecular formula: C19H44NO6P. Mole weight: 413.53. |  |
| C16-PAF | C16-PAF (PAF (C16)), a phospholipid mediator, is a platelet-activating factor and ligand for PAF G-protein-coupled receptor (PAFR). C16-PAF exhibits anti-apoptotic effect and inhibits caspase-dependent death by activating the PAFR. C16-PAF is a potent MAPK and MEK/ERK activator. C16-PAF induces increased vascular permeability[1][2][3][4][5]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: PAF (C16). CAS No. 74389-68-7. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-108635. |  |
| C16 PEG2000 Ceramide | C16 PEG2000 Ceramide is a polyethylene glycolylated ceramide. C16 PEG2000 Ceramide can be used for lipid carrier to delivery. C16 PEG2000 Ceramide induces autophagy. C16 PEG2000 Ceramide can be used for cancer research[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: C16 PEG Ceramide (MW 2000). CAS No. 212116-78-4. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-144005. | |
| C16-Sphingosine | C16-Sphingosine. Group: Biochemicals. Alternative Names: (2S,3R,4E)-2-Amino-4-hexadecene-1,3-diol; (E)-D-Erythro-2-amino-4-hexadecene-1,3-diol; [R-[R*,S*-(E)]]-2-Amino-4-hexadecene-1,3-diol; C16-Sphingosine; 16:Sphingosine; C16-Sphingosine; Hexadecasphing-4-enine; Hexadecasphingenine. Grades: Highly Purified. CAS No. 6982-9-8. Pack Sizes: 10mg. Molecular Formula: C16H33NO2, Molecular Weight: 271.44. US Biological Life Sciences. |  Worldwide |
| C17:0 anandamide phosphate | C17:0 anandamide phosphate. Group: Others. Purity: >99%. Mole weight: 415.48. Stability: 1 Year. Storage: -20°C. Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C17:0 anandamide phosphate; Heptadecanoyl ethanolamide phosphate (sodium salt). Cat No: FLBZ-080. |  |
| C17:0 GA2 | C17:0 GA2, the renowned biomarker utilized in the biomedical realm, serves as an undeniably valuable asset for diagnosing the genetic ailment, namely Gaucher disease, which is fundamentally instigated by the inadequacy of glucocerebrosidase. Remarkably, the levels of C17:0 GA2 are considerably heightened in both blood and urine of afflicted individuals, rendering it an efficacious tool for the prompt detection and progressive monitoring of the disease. Alternative Names: C17:0 Galabiosylceramide; N-[(1S,2R,3E)-1-[[(4-O-α-D-Galactopyranosyl-β-D-galactopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]heptadecanamide. Grades: >99%. CAS No. 2315262-51-0. Molecular formula: C47H89NO13. Mole weight: 876.21. | |
| C17:0 iGB3 | C17:0 iGb3, a synthetic analogue of iGb3 that plays a pivotal role in immunostimulation. With its unique glycolipid composition, this powerful compound has exhibited promising potential in the treatment of cancer by priming the immune system against malignant cells. Moreover, recent research suggests that C17:0 iGb3 may also hold therapeutic promise in the management of infectious diseases and autoimmune disorders. Discover the cutting-edge scientific complexities behind C17:0 iGb3 and its potential impact on human health. Alternative Names: C17:0 Isoglobotriaosylceramide; N-[(1S,2R,3E)-1-[[(O-α-D-Galactopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]heptadecanamide. Grades: >99%. CAS No. 2315262-50-9. Molecular formula: C53H99NO18. Mole weight: 1038.35. | |
| C-176 | STING inhibitor C-176 is a potent, small-molecule inhibitor of STING, a central signaling component of the intracellular DNA sensing pathway. Group: Inhibitors. CAS No. 314054-00-7. Pack Sizes: 5mg. Product ID: S6575. Formula: C11H7IN2O4. Smiles: C1=CC(=CC=C1NC(=O)C2=CC=C(O2)[N+](=O)[O-])I. Storage Conditions: 3 years -20°C powder. |  United States; Europe |
| C-176 | C-176 is a selective and blood-brain barrier permeable STING inhibitor. C-176 covalently targets transmembrane cysteine residue 91 and thereby blocking activation-induced palmitoylation of STING[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 314054-00-7. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-112906. | |
| C-178 | C-178 is a potent and selective covalent inhibitor of STING. C-178 binds to Cys91 and suppresses the STING responses elicited by distinct bona fide activators in mouse but not human[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 329198-87-0. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 250 mg; 500 mg. Product ID: HY-123963. | |
| C18:0 L-carnitine-d9 (HCl salt) | C18:0 L-carnitine-d9 (HCl salt). Alternative Names: Stearoyl L-carnitine-d9 (HCl salt). CAS No. 2936622-19-2. Purity: >99%. Product ID: ALCFA2936622192. Molecular formula: C25H41D9ClNO4. Mole weight: 473.18. Alfa Chemistry - ISO 9001:32057 Certified. |  |
| C18:1-Ceramide | C18:1-Ceramide is a ceramide subspecies. C18:1-Ceramide can be used in the study of type 2 diabetes[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 5966-28-9. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-141578. | |
| C18:1 Ceramide-1-Phosphate (d18:1/18:1(9Z)) | C18:1 Ceramide-1-Phosphate (d18:1/18:1(9Z)). Alternative Names: N-oleoyl-ceramide-1-phosphate (ammonium salt). CAS No. 1246304-33-5. Purity: >99%. Product ID: ALCFA1246304335. Molecular formula: C36H73N2O6P. Mole weight: 660.948. Alfa Chemistry - ISO 9001:32057 Certified. | |
| C18:1 Galactosyl(ss) Ceramide (d18:1/18:1(9Z)) | C18:1 Galactosyl(ss) Ceramide (d18:1/18:1(9Z)). Group: Others. Synonyms: C18:1 ss-D-galactosyl ceramide; N-(9Z-octadecenoyl)-1-ss-galactosyl-sphing-4-enineGalCer(d18:1/18:1(9Z)). Purity: >99%. Mole weight: 726.079. Stability: 6 Months. Storage: -20°C. C18:1 ss-D-galactosyl ceramide; N-(9Z-octadecenoyl)-1-ss-galactosyl-sphing-4-enineGalCer(d18:1/18:1(9Z)); C18:1 Galactosyl(ss) Ceramide (d18:1/18:1(9Z)); D-galactosyl-ss-1,1'-N-oleoyl-D-erythro-sphingosine. Cat No: SPHZ-072. | |
| C18:1 Lactosyl(ss) Ceramide (d18:1/18:1) | C18:1 Lactosyl(ss) Ceramide (d18:1/18:1). Group: Others. Mole weight: 888.219. Stability: 6 Months. Storage: -20°C. C18:1 Lactosyl(ss) Ceramide (d18:1/18:1); D-lactosyl-ss-1,1' N-oleyol-D-erythro-sphingosine. Cat No: SPHZ-065. | |
| C18:1 L-carnitine-d9 | C18:1 L-carnitine-d9. Alternative Names: Oleoy L-carnitine-d9. CAS No. 2847775-85-1. Purity: >99%. Product ID: ALCFA2847775851. Molecular formula: C25H38D9NO4. Mole weight: 434.71. Alfa Chemistry - ISO 9001:32057 Certified. | |
| C18:2 anandamide phosphate | C18:2 anandamide phosphate. Group: Others. Purity: >99%. Mole weight: 425.482. Stability: 3 Months. Storage: -20°C. Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C18:2 anandamide phosphate; Linoleoyl ethanolamide phosphate (sodium salt). Cat No: FLBZ-075. | |
| C18:2 L-carnitine-d9 | C18:2 L-carnitine-d9. Alternative Names: Linoleoy L-carnitine-d9. CAS No. 2847775-86-2. Purity: >99%. Product ID: ALCFA2847775862. Molecular formula: C25H36D9NO4. Mole weight: 432.69. Alfa Chemistry - ISO 9001:32057 Certified. | |
| C18(2R-OH) Galactosyl(ss) Ceramide | C18(2R-OH) Galactosyl(ss) Ceramide. Group: Others. Purity: >99%. Mole weight: 744.094. Stability: 6 Months. Storage: -20°C. C18(2R-OH) Galactosyl(ss) Ceramide; D-galactosyl-ss1-1'-N-[2"(R)-hydroxystearoyl]-D-erythro-sphingosine. Cat No: SPHZ-074. | |
| C18(2S-OH) Galactosyl(ss) Ceramide | C18(2S-OH) Galactosyl(ss) Ceramide. Group: Others. Purity: >99%. Mole weight: 744.094. Stability: 6 Months. Storage: -20°C. C18(2S-OH) Galactosyl(ss) Ceramide; D-galactosyl-ss1-1'-N-[2"(S)-hydroxystearoyl]-D-erythro-sphingosine. Cat No: SPHZ-075. | |
| C188 | C188 (CPD188) is a STAT3 inhibitor with anticancer effects. C188 inhibits STAT3 SH2/pY-peptide binding (IC50 of 20 μM against pY-peptide binding) and IL-6-mediated STAT3 phosphorylation. C188 is selective for STAT3 over STAT1. C188 inhibits nuclear-to-cytoplasmic translocation of Stat3. C188 shows highly active induces apoptosis in breast cancer cell lines with constitutive Stat3 activation (EC50s of 0.73 μM, 3.96 μM, and 7.01 μM in MDA-MB-468, MDA-MB-231, and MDA-MB-435 cultures, respectively)[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: CPD188. CAS No. 823828-18-8. Pack Sizes: 5 mg. Product ID: HY-112338. | |
| C188-9 | C188-9 (TTI-101) is a STAT3 inhibitor with a Kd value of 4.7 nM. C188-9 targets the SH2 domain of STAT3, blocks the processes of STAT3 ligand binding, receptor recruitment, homodimerization and phosphorylation, and regulates STAT3-mediated genes associated with tumorigenesis and radioresistance. C188-9 regulates STAT1-mediated genes related to radioresistance and reduces the activation level of STAT1. C188-9 downregulates the expression of DNMT1, enhances DAC-induced demethylation and re-expression of RASSF1A, and simultaneously potentiates the anti-tumor effect of DAC on pancreatic cancer cells. C188-9 inhibits both anchorage-dependent and anchorage-independent growth of cancer cells, induces Apoptosis, blocks the growth of tumor xenografts, and suppresses muscle atrophy. C188-9 maintains muscle mass, increases body weight and improves grip strength in tumor-bearing mice. C188-9 can be used in research related to head and neck squamous cell carcinoma, pancreatic cancer, sepsis-related skeletal muscle wasting, non-small cell lung cancer, acute myeloid leukemia and cancer cachexia[1][2][3][4][5][6]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: TTI-101. CAS No. 432001-19-9. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-112288. | |
| C188-9 (TTI-101) | C188-9 (TTI 101) is a potent inhibitor of STAT3 that binds to STAT3 with high affinity (KD=4.7±0.4 nM). C188-9 is well tolerated in mice, shows good oral bioavailability, and is concentrated in tumors. Group: Inhibitors. Alternative Names: TTI 101. CAS No. 432001-19-9. Pack Sizes: 5mg. Product ID: S8605. Formula: C27H21NO5S. Smiles: COC1=CC=C(C=C1)S(=O)(=O)NC2=CC(=C(C3=CC=CC=C32)O)C4=C(C=CC5=CC=CC=C54)O. Storage Conditions: 2 years -80 in solvent. | United States; Europe |
| C18 Alkyl Acrylate | C18 Alkyl Acrylate. |  |
| C18 Alkyl Methacrylate | C18 Alkyl Methacrylate. | |
| C18 ceramide | It is an endogenous bioactive sphingolipid. Uses: The sphingolipid ceramide. Alternative Names: N-Stearoyl-D-erythro-sphingosine; N-(octadecanoyl)-sphing-4-enine; C18 Ceramide (d18:1/18:0); N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]octadecanamide; D-erythro-1,3-Dihydroxy-2-octadecanoylamido-trans-4-octadecene; N-Stearoyl-C18-sphingosine; N-Stearoyl-D-sphingosine; N-Stearoylsphingenine; N-Stearoylsphingosine; N-octadecanoylsphingosine; C18 Cer; N-(stearoyl)-ceramide; Cer(d18:1/18:0). Grades: 98%. CAS No. 2304-81-6. Molecular formula: C36H71NO3. Mole weight: 565.95. | |
| C18-Ceramide (d18:1/18:0) | C18-Ceramide (d18:1/18:0) is a bioactive molecule with multiple functions in cells, not a traditional agonist or inhibitor targeting a single site. It can act on multiple cellular targets, such as proteins related to endoplasmic reticulum stress (e.g., ATF-4, XBP-1, CHOP), proteins in the PI3K/AKT signaling pathway, and SNARE complex proteins. It exerts activities like inducing cell death, promoting autophagy, and regulating exocytosis through mechanisms such as activating endoplasmic reticulum stress, inhibiting the PI3K/AKT signaling pathway, and affecting lipid raft - related functions. It can be used in research on the mechanism of neuronal injury in the field of neuroscience and in the treatment research of cancers such as glioma in the field of oncology[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: C18-Ceramide. CAS No. 2304-81-6. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-100355. | |
| C18-Ceramide-d7 | C18-Ceramide-d7 is deuterium labeled C18-Ceramide. Uses: Scientific research. Category: Signaling pathways. CAS No. 1840942-14-4. Pack Sizes: 500 μg (1.75 mM * 500 μL in Methanol:Chloroform (10:90)); 1 mg; 5 mg. Product ID: HY-100355S1. | |
| C18 dihydroceramide | C18 dihydroceramide. Group: Biochemicals. Alternative Names: N- [ (1S, 2R) -2-Hydroxy-1- (hydroxymethyl) heptadecyl] octadecanamide; Dihydroceramide; N-Stearoylsphinganine. Grades: Highly Purified. CAS No. 2304-80-5. Pack Sizes: 2mg, 5mg, 10mg, 25mg, 50mg. Molecular Formula: C36H73NO3. US Biological Life Sciences. | Worldwide |
| C18 Dihydroceramide (N-Stearoylsphinganine, Octadecanoyl sphinganine) | C18 Dihydroceramide (N-Stearoylsphinganine, Octadecanoyl sphinganine). Group: Biochemicals. Alternative Names: N-Stearoylsphinganine; Octadecanoyl sphinganine. Grades: Highly Purified. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| c18e6 | c18e6. Alternative Names: HEXAETHYLENE GLYCOL MONOOCTADECYL ETHER;C18E6;OCTADECYLHEXAGLYCOL;POLYOXYETHYLENE 6 STEARYL ETHER;3,6,9,12,15,18-hexaoxahexatriacontan-1-ol;STEARETH-6;C18E6, Octadecylhexaglycol, Polyoxyethylene (6) stearyl ether;2-[2-[2-[2-[2-(2-octadecoxyethoxy)et. CAS No. 2420-29-3. Molecular formula: C30H62O7. Mole weight: 534.81. Purity: 96%. IUPAC Name: 2-[2-[2-[2-[2-(2-octadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol. | |
| C18 Galactosyl(ss) Ceramide (d18:1/18:0) | C18 Galactosyl(ss) Ceramide (d18:1/18:0). Group: Others. Purity: >99%. Mole weight: 728.094. Stability: 1 Year. Storage: -20°C. C18 Galactosyl(ss) Ceramide (d18:1/18:0); D-galactosyl-ss-1,1-N'-stearoyl-D-erythro-sphingosine. Cat No: SPHZ-071. | |
| C18 Glucosyl(β) Ceramide-[d5] | C18 Glucosyl(β) Ceramide-[d5]. Alternative Names: D-glucosyl-β-1,1'-N-stearoyl-D-erythro-sphingosine-d5; C18 Glucosyl(β) Ceramide-d5; beta-D-glucosyl-N-octadecanoylsphingosine-d5; GlcCer(d18:1/18:0)-d5; Glucosylceramide (d18:1/18:0)-d5; beta-D-glucosyl-N-stearoylsphingosine-d5; 1-O-(beta-D-Glucopyranosyl)-N-octadecanoylsphingosine-d5. Grades: >99%. CAS No. 2260670-13-9. Molecular formula: C42H76D5NO8. Mole weight: 733.13. | |
| C18 Lactosyl(beta) Ceramide (d18:1/18:0) | C18 Lactosyl(beta) Ceramide (d18:1/18:0). This product is a ceramide compound that plays a role in the treatment of various diseases, including cancer and neurodegenerative disorders. It has potential therapeutic applications in drug delivery and targeted therapy for specific cell types within the biomedical field. Alternative Names: D-lactosyl-beta-1,1' N-stearoyl-D-erythro-sphingosine; C18 beta-D-Lactosyl Ceramide; Lactosylceramide; beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-octadecanoylsphingosine; LacCer(d18:1/18:0). Grades: >99%. CAS No. 125712-73-4. Molecular formula: C48H91NO13. Mole weight: 890.24. | |
| C18(Plasm)-18:1 PE | C18(Plasm)-18:1 PE, a phospholipid, is frequently employed in drug delivery systems owing to its capacity for drug encapsulation targeting therapy. Moreover, it plays a crucial role in modulating cellular signaling cascades and has garnered attention for its prospective therapeutic applications towards cancer and other ailments. Alternative Names: 1-(1Z-octadecenyl)-2-oleoyl-sn-glycero-3-phosphoethanolamine; 1-O-1'-(Z)-octadecenyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine; PE(P-18:0/18:1(9Z)). Grades: >99%. CAS No. 144371-68-6. Molecular formula: C41H80NO7P. Mole weight: 730.05. | |
| C18(Plasm)-20:4 PE | C18(Plasm)-20:4 PE is a phosphatidylethanolamine (PE) compound composed of a C18 acyl chain and a 20:4 polyunsaturated fatty acid. Known for its pivotal role in cell membrane organization and operation, research indicates promising therapeutic prospects in the realms of inflammatory disorders and oncological interventions. Alternative Names: 1-(1Z-octadecenyl)-2-arachidonoyl-sn-glycero-3-phosphoethanolamine; 1-O-1'-(Z)-octadecenyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine; 1-(1-enyl-stearoyl)-2-arachidonoyl-GPE; GPEtn(18:0p/20:4(5Z,8Z,11Z,14Z)). Grades: >99%. CAS No. 144371-69-7. Molecular formula: C43H78NO7P. Mole weight: 752.06. | |
| C18(Plasm)-22:6 PE | C18(Plasm)-22:6 PE, a phosphatidylethanolamine variant, encompasses a C18 chain combined with a plasmalogen entity. Positioned at the sn-2 locus is a docosahexaenoic acid (22:6). The lipid's significance lies in its contribution to cell membrane integrity and functionality, correlating with neuroprotection and anti-inflammatory properties. Alternative Names: 1-(1Z-octadecenyl)-2-docosahexaenoyl-sn-glycero-3-phosphoethanolamine; 1-O-1'-(Z)-octadecenyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine; GPEtn(18:0p/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); 1-(1Z-octadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine; GPE(P-18:0/22:6); 1-(1-enyl-stearoyl)-2-docosahexaenoyl-GPE. Grades: >99%. CAS No. 206059-98-5. Molecular formula: C45H78NO7P. Mole weight: 776.08. | |
| C18(Plasm) LPE | C18(Plasm) LPE, a prominent lipid compound utilized in the field of biomedical research, serves as a pivotal tool in the investigation of various ailments like cancer and inflammatory disorders. Its indispensable contribution to drug development and targeted therapy stems from its significant involvement in cell signaling mechanisms and membrane-related functionalities. Alternative Names: 1-O-1'-(Z)-octadecenyl-2-hydroxy-sn-glycero-3-phosphoethanolamine; phosphoethanolamine (P-18:0); PE(18:1p/0:0). Grades: >99%. CAS No. 174062-73-8. Molecular formula: C23H48NO6P. Mole weight: 465.60. | |
| C18(plasm) MG | C18(plasm) MG, a sophisticated chemical compound predominantly employed in the field of biomedicine for the precise purification and isolation of plasmid DNA, finds significant utility in molecular biology research. Its adeptness in extracting particular genes and enabling gene therapy innovation in diverse disease contexts underscores its pivotal role in advancing scientific understanding. Alternative Names: 1-O-1'-(Z)-octadecenyl-sn-glycerol; 1-(1Z-Octadecenyl)-sn-glycerol; MG(P-18:0e/0:0/0:0). Grades: >99%. CAS No. 18330-10-4. Molecular formula: C21H42O3. Mole weight: 342.56. | |
| C-19393 E5 | It is produced by the strain of Streptomyces griseus subsp. cryophilus C-19393. C-19393 E5 has anti-gram-positive and anti-gram-negative bacteria activity and strong β-lactamase inhibition. Alternative Names: Antibiotic C 19393E5; C-19393 E(5). CAS No. 83310-72-9. Molecular formula: C13H16N2O6S. Mole weight: 328.34. | |
| C19 3'-Sulfo galactosylceramide (d18:1/19:0) | C19 3'-Sulfo Galactosylceramide (d18:1/19:0) is a synthetic derivative of sulfatide[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: (3'-Sulfo)Galβ-ger(d18:1/19:0); C19 Sulfatide. CAS No. 2692623-78-0. Pack Sizes: 1 mg. Product ID: HY-159251. | |
| C-19 steroid 1α-hydroxylase | The enzyme, characterized from the bacterium Sorangium cellulosum, is a class I cytochrome P-450, and uses ferredoxin as its electron donor. It was shown to act on several C-19 steroid substrates, including testosterone, androstenedione, testosterone-acetate and 11-oxoandrostenedione. Group: Enzymes. Synonyms: CYP260A1. Enzyme Commission Number: EC 1.14.15.19. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-0944; C-19 steroid 1α-hydroxylase; EC 1.14.15.19; CYP260A1. Cat No: EXWM-0944. | |
| C-(1-Bromo-1-deoxy-2,3,4,6-tetra-O-benzoyl-b-D-glucopyranosyl)formamide | C-(1-Bromo-1-deoxy-2,3,4,6-tetra-O-benzoyl-b-D-glucopyranosyl)formamide is a vital component in the development of novel antiviral drugs. Through its unique chemical structure, it exhibits potent antiviral activity against a range of infectious diseases, including influenza and herpes viruses. Alternative Names: C-(2,3,4,6-Tetra-O-benzoyl-1-bromo-1-deoxy-b-D-glucopyranosyl)formamide. CAS No. 262849-68-3. Molecular formula: C35H28BrNO10. Mole weight: 702.50. | |
| c-(1-Cyclopentyl-piperidin-4-yl)-methylamine | c-(1-Cyclopentyl-piperidin-4-yl)-methylamine. CAS No. 132864-60-9. Product ID: ACM132864609. Molecular formula: C11H22N2. Mole weight: 182.31. Alfa Chemistry - ISO 9001:32057 Certified. | |
| C1 ESTERASE INHIBITOR | C1 ESTERASE INHIBITOR. Alternative Names: C1 ESTERASE INHIBITOR; C1-ESTERASE INHIBITOR, HUMAN; C1 ESTERASE INHIBITOR, HUMAN ANTIGEN; C1 INIHIBITOR (ESTERASE INIHIBITOR); COMPLEMENT C1-ESTERASE INHIBITOR, HUMAN; ESTERASE INHIBITOR C-1; esterase inhibitor C-1 from*human plasma; V:C1esteraseinhibitor. CAS No. 80295-38-1. | |
| c-(1-Methyl-1H-imidazol-2-yl)-c-p-tolyl-methylamine dihydrochloride | c-(1-Methyl-1H-imidazol-2-yl)-c-p-tolyl-methylamine dihydrochloride. Alternative Names: 1216236-39-3, CTK4B2554, MolPort-004-968-009, AKOS015845179, AG-L-20964, FT-0681768, I05-1628, (1-methylimidazol-2-yl)(4-methylphenyl)methanamine dihydrochloride, c-(1-methyl-1h-imidazol-2-yl)-c-p-tolyl-methylamine dihydrochloride. CAS No. 1216236-39-3. Purity: 96%. Product ID: ACM1216236393. Molecular formula: C12H17Cl2N3. Mole weight: 274.2. IUPAC Name: (1-methylimidazol-2-yl)-(4-methylphenyl)methanamine;dihydrochloride. Alfa Chemistry - ISO 9001:32057 Certified. | |
| c-(1-Methyl-pyrrolidin-3-yl)-methylamine | c-(1-Methyl-pyrrolidin-3-yl)-methylamine. Alternative Names: C-(1-METHYL-PYRROLIDIN-3-YL)-METHYLAMINE;CHEMBRDG-BB 4003800;AKOS BC-1213;Dimethylaminopyrrolidine;3-(Aminomethyl)-1-methylpyrrolidine;N,1-Dimethylpyrrolidin-3-amine. CAS No. 13005-11-3. Product ID: ACM13005113. Molecular formula: C6H14N2. Mole weight: 114.19. Alfa Chemistry - ISO 9001:32057 Certified. | |
| C1Q, HUMAN | C1Q, HUMAN. Alternative Names: C1Q, HUMAN; COMPLEMENT COMPONENT C1Q; COMPLEMENT C1Q, HUMAN; COMPLEMENT C1Q PROTEIN; COMPLEMENT C1Q PROTEIN HUMAN; COMPLEMENT 1Q, HUMAN; COMPLEMENT COMPONENT C1Q FROM HUMAN*SERUM; activity:18-30units / mgproteinsalt-free,lyophilizedsolidbysds. Grades: 95%. CAS No. 80295-33-6. | |
| C1s-IN-1 trihydrochloride | C1s-IN-1 trihydrochloride (Compound A1) is the selective inhibitor for C1s protease with the Ki of 5.8 μM. C1s-IN-1 trihydrochloride inhibits cleavage of C2 by C1s with an IC50 of 85 μM, inhibits the activation of classic pathway with an IC50 of 22 μM. C1s-IN-1 trihydrochloride is the competitive inhibitor for thrombin with the Ki of 51.2 μM[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1376162-36-5. Pack Sizes: 10 mM * 1 mL in DMSO; 25 mg; 50 mg. Product ID: HY-W371165. | |
| C20:4 Anandamide phosphate | C20:4 Anandamide phosphate. Group: Others. Purity: >99%. Mole weight: 449.496. Stability: 3 Months. Storage: -20°C. Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C20:4 Anandamide phosphate; Arachidonoyl ethanolamide phosphate (sodium salt). Cat No: FLBZ-066. | |
| C20 Ceramide | C20 Ceramide is a N-acylsphingosine in which the ceramide N-acyl group is specified as eicosanoyl. It has a role as a mouse metabolite. It is a N-acylsphingosine and a Cer(d38:1). It is functionally related to an icosanoic acid. Alternative Names: N-Eicosanoylsphingosine; N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl]Eicosanamide; (E)-D-erythro- N-[2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl]Eicosanamide; [R-[R*,S*-(E)]]-N-[2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl]Eicosanamide; N-(Eicosanoyl)-D-erythro-1,3-dihydroxy-2-amino-4-trans-octadecene; N-(Eicosanoyl)sphingosine; N-Eicosanoyl-C18-sphingosine. CAS No. 7344-2-7. Molecular formula: C38H75NO3. Mole weight: 594. | |
| C20-Ceramide | C20-Ceramide. Group: Biochemicals. Alternative Names: N-Eicosanoylsphingosine; N- [ (1S, 2R, 3E) -2-Hydroxy-1- (hydroxymethyl) -3-heptadecenyl] eicosanamide; (E)-D-erythro- N- [2-hydroxy-1- (hydroxymethyl) -3-heptadecenyl] eicosanamide. Grades: Highly Purified. CAS No. 7344-2-7. Pack Sizes: 2mg, 5mg, 10mg, 25mg, 50mg. Molecular Formula: C38H75NO3. US Biological Life Sciences. | Worldwide |
| C20 dihydroceramide | C20 dihydroceramide. Group: Biochemicals. Alternative Names: N-Eicosanoylsphinganine; N-[2-hydroxy-1- (hydroxymethyl) heptadecyl]-[R- (R*, S*) ]-eicosanamide. Grades: Highly Purified. CAS No. 121459-06-1. Pack Sizes: 2mg, 5mg, 10mg, 25mg, 50mg. Molecular Formula: C38H77NO3. US Biological Life Sciences. | Worldwide |
| C20 Dihydroceramide (N-Eicosanoylsphinganine) | C20 Dihydroceramide (N-Eicosanoylsphinganine). Group: Biochemicals. Alternative Names: N-Eicosanoylsphinganine. Grades: Highly Purified. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| C2:0 L-carnitine-d9 | C2:0 L-carnitine-d9. Alternative Names: ethanoyl L-carnitine-d9. CAS No. 203805-90-7. Purity: >99%. Product ID: ALCFA203805907. Molecular formula: C9H8D9NO4. Mole weight: 212.29. Alfa Chemistry - ISO 9001:32057 Certified. | |
| C20-OtBu-Glu-OtBu | C20-OtBu-Glu-OtBu. Alternative Names: (S)-2-(19-tert-Butoxycarbonylnonadecanoylamino)pentanedioic acid 1-tert-butyl ester; (S)-5-(tert-Butoxy)-4-(20-(tert-butoxy)-20-oxoicosanamido)-5-oxopentanoic acid. CAS No. 1119061-70-9. Molecular formula: C33H61NO7. Mole weight: 583.85. | |
| C 21 | C 21 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor (IC50 = 1.8 μM) with 5-fold selectivity for PRMT1 over PRMT6 and >250-fold selectivity over PRMT3 and CARM1. Alternative Names: C21; C-21; N-Acetyl-L-serylglycyl-N5-(2-chloroethanimidoyl)-L-ornithylglycyl-L-lysylglycylglycyl-L-lysylglycyl-L-leucylglycyl-L-lysylglycylglycyl-L-alanyl-L-lysyl-L-arginyl-L-histidyl-L-arginyl-L-lysyl-L-valine. Grades: >98%. CAS No. 1229236-78-5. Molecular formula: C90H161ClN36O24. Mole weight: 2166.92. | |
| C22 Ceramide | C22 Ceramide. Alternative Names: N-[(3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-docosanamide. CAS No. 869501-30-4. Molecular formula: C40H79NO3. Mole weight: 622.06. | |
| C22-Ceramide | C22-Ceramide. Group: Biochemicals. Alternative Names: N-[(3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-docosanamide. Grades: Highly Purified. CAS No. 869501-30-4. Pack Sizes: 2mg, 5mg, 10mg, 25mg, 50mg. Molecular Formula: C40H79NO3. US Biological Life Sciences. | Worldwide |
| C22 Ceramide (d14:1/22:0) | C22 Ceramide (d14:1/22:0). Group: Others. Purity: >99%. Mole weight: 565.954. Stability: 1 Year. Storage: -20°C. C22 Ceramide (d14:1/22:0); N-behenoyl-D-erythro-sphingosine (C14 base). Cat No: SPHZ-145. | |
| C22-Ceramide (d18:1/22:0) | C22-Ceramide (d18:1/22:0) (Cer d18:1/22:0) is an endogenous bioactive sphingolipid. C22-Ceramide (d18:1/22:0) reduces the propensity of C16-ceramide channel formation in isolated rat liver mitochondria and in liposomes[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: N-Behenoyl-D-erythro-sphingosine; C22-Ceramide; Cer d18:1/22:0. CAS No. 27888-44-4. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-154831. | |
| C22 dihydroceramide | C22 dihydroceramide. Group: Biochemicals. Alternative Names: N-[(1S,2R)-2-Hydroxy-1-(hydroxymethyl)-heptadecyl]-docosanamide. Grades: Highly Purified. CAS No. 147492-65-7. Pack Sizes: 2mg, 5mg, 10mg, 25mg, 50mg. Molecular Formula: C40H81NO3. US Biological Life Sciences. | Worldwide |
| C22 Dihydroceramide (N-[(1S,2R)-2-Hydroxy-1-(hydroxymethyl)-heptadecyl]-docosanamide) | C22 Dihydroceramide (N-[(1S,2R)-2-Hydroxy-1-(hydroxymethyl)-heptadecyl]-docosanamide). Group: Biochemicals. Alternative Names: N-[(1S,2R)-2-Hydroxy-1-(hydroxymethyl)-heptadecyl]-docosanamide. Grades: Highly Purified. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| C-(2,3,4,6-Tetra-O-acetyl-1-azido-1-deoxy-a-D-galactopyranosyl)formamide | C-(2,3,4,6-Tetra-O-acetyl-1-azido-1-deoxy-a-D-galactopyranosyl)formamide is a valuable compound utilized in the biomedical industry for its potential in treating infectious diseases caused by specific bacteria or viruses. Its structure and chemical properties make it an effective candidate for the development of antiviral or antibacterial drugs. Alternative Names: C-(2,3,4,6-Tetra-O-acetyl-1-azido-1-deoxy-alpha-D-galactopyranosyl)formamide. CAS No. 180904-09-0. Molecular formula: C15H20N4O10. Mole weight: 416.34. | |
| C-(2,3,4,6-Tetra-O-acetyl-1-bromo-1-deoxy-b-D-galactopyranosyl)formamide | C-(2,3,4,6-Tetra-O-acetyl-1-bromo-1-deoxy-b-D-galactopyranosyl)formamide, an extensively researched and promising biomedical compound, exhibits immense potential for therapeutic applications. With its commendable prowess as a glycosylation reagent in synthesizing glycosides, oligosaccharides, and bioactive molecules, this exceptional product assumes a pivotal role in drug development. Alternative Names: α-D-galacto-2-Heptulopyranosonamide, 2-bromo-2-deoxy-, 3,4,5,7-tetraacetate. CAS No. 159895-07-5. Molecular formula: C15H20BrNO10. Mole weight: 454.22. | |
| C-(2,3,4,6-Tetra-O-acetyl-1-hydroxy-b-D-galactopyranosyl)formamide | C-(2,3,4,6-Tetra-O-acetyl-1-hydroxy-b-D-galactopyranosyl)formamide is a compound used in the research of various diseases playing a crucial role in targeting specific cellular pathways associated with compound resistance and cancer progression. Alternative Names: C-(2,3,4,6-Tetra-O-acetyl-1-hydroxy-beta-D-galactopyranosyl)formamide. CAS No. 189633-60-1. Molecular formula: C15H21NO11. Mole weight: 391.33. | |
| C-(2,3,4-Tri-O-acetyl-1-azido-1-deoxy-b-D-galactopyranosyl)formamide | C-(2,3,4-Tri-O-acetyl-1-azido-1-deoxy-b-D-galactopyranosyl)formamide, a renowned compound extensively applied within the biomedical industry, emerges as an indubitably vital asset enhancing drug development and research endeavors. It manifests considerable potential in ameliorating an array of ailments, predominantly those entrenched in the realms of cellular and molecular biology. Alternative Names: α-D-arabino-2-Hexulopyranosonamide, 2-azido-2-deoxy-, 3,4,5-triacetate (9CI). CAS No. 189633-67-8. Molecular formula: C12H16N4O8. Mole weight: 344.28. | |
| C-(2,3,4-Tri-O-acetyl-1-hydroxy-b-D-galactopyranosyl)formamide | C-(2,3,4-Tri-O-acetyl-1-hydroxy-b-D-galactopyranosyl)formamide is a biomedical product used for the study of certain diseases. It acts as a formamide derivative of galactose, which exhibits potential antitumor activity against various cancer types. Alternative Names: β-D-arabino-2-Hexulopyranosonamide, 3,4,5-triacetate (9CI). CAS No. 189633-66-7. Molecular formula: C12H17NO9. Mole weight: 319.26. | |
| C24:1 b-D-Galactosyl ceramide | C24:1 b-D-Galactosyl ceramide is a renowned compound prevalent in the ever-evolving biomedical realm, specifically tailored for the research of diverse afflictions, including Gaucher disease and Fabry disease. Alternative Names: Galactosyl-b-1,1 N-nervonoyl-D-erythro-sphingosine. Grades: >99%. CAS No. 17283-91-9. Molecular formula: C48H91NO8. Mole weight: 810.24. | |
| C24:1Ceramide | C24:1Ceramide. Group: Biochemicals. Alternative Names: Nervonic ceramide. Grades: Highly Purified. CAS No. 54165-50-0. Pack Sizes: 2mg, 5mg, 10mg, 25mg, 50mg. Molecular Formula: C42H81NO3. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
